The role of anxiety in metabolic syndrome

References

• Hamer M, Molloy GJ, Stamatakis E. Psychological distress as a risk factor for cardiovascular events: pathophysiological and behavioral mechanisms. J. Am. Coll. Cardiol.52(25), 2156–2162 (2008).
   PubMed Web of Science ®Google Scholar
• Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation99(16), 2192–2217 (1999).
   PubMed Web of Science ®Google Scholar
• Skala JA, Freedland KE, Carney RM. Coronary heart disease and depression: a review of recent mechanistic research. Can. J. Psychiatr.51(12), 738–745 (2006).
   PubMed Web of Science ®Google Scholar
• Albert D. Risk in cardiovascular disease. Absolute cardiovascular risk is not most appropriate measure to use. BMJ Clin. Res. Ed.321(7254), 175 (2000).
   PubMedGoogle Scholar
• Coryell W, Noyes R, Clancy J. Excess mortality in panic disorder. A comparison with primary unipolar depression. Arch. General Psychiatr.39(6), 701–703 (1982).
   PubMed Web of Science ®Google Scholar
• Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch. General Psychiatr.65(1), 62–71 (2008).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med.15(7), 539–553 (1998).
   PubMed Web of Science ®Google Scholar
• Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet. Med.16(5), 442–443 (1999).
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel 3). JAMA285(19), 2486–2497 (2001).
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American heart association conference on scientific issues related to definition. Arterioscler. Thromb. Vasc. Biol.24(2), e13–e18 (2004).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet366(9491), 1059–1062 (2005).
   PubMed Web of Science ®Google Scholar
• Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med.9, 48 (2011).
   PubMed Web of Science ®Google Scholar
• Alberti KG, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation120(16), 1640–1645 (2009).
   PubMed Web of Science ®Google Scholar
• Cornier MA, Dabelea D, Hernandez TL et al. The metabolic syndrome. Endocr. Rev.29(7), 777–822 (2008).
   PubMed Web of Science ®Google Scholar
• Procopiou M, Philippe J. The metabolic syndrome and Type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc. Dis.20(Suppl. 1), S2–S8 (2005).
   PubMedGoogle Scholar
• Cohen BE, Panguluri P, Na B, Whooley MA. Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the heart and soul study. Psychiatr. Res.175(1–2), 133–137 (2010).
   PubMed Web of Science ®Google Scholar
• Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC. The relationship between depression and diabetes mellitus: findings from the Hertfordshire cohort study. Diabet. Med.26(6), 641–648 (2009).
   PubMed Web of Science ®Google Scholar
• Scheen AJ. The endocannabinoid system: a promising target for the management of Type 2 diabetes. Curr. Protein Peptide Sci.10(1), 56–74 (2009).
   PubMed Web of Science ®Google Scholar
• Rosolová H, Podlipný J. Anxious–depressive disorders and metabolic syndrome. Vnitrni Lekarstvi55(7–8), 650–652 (2009).
   PubMedGoogle Scholar
• Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J. Psychosom. Res.62(1), 31–38 (2007).
   PubMed Web of Science ®Google Scholar
• Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann. NY Acad. Sci.1179, 153–166 (2009).
   PubMed Web of Science ®Google Scholar
• Reagan LP, Grillo CA, Piroli GG. The As and Ds of stress: metabolic, morphological and behavioral consequences. Eur. J. Pharmacol.585(1), 64–75 (2008).
   PubMed Web of Science ®Google Scholar
• Licht CM, Vreeburg SA, van Reedt Dortland AK et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic–pituitary–adrenal axis activity is associated with metabolic abnormalities. J. Clin. Endocrinol. Metab.95(5), 2458–2466 (2010).
   PubMed Web of Science ®Google Scholar
• Takeuchi T, Nakao M, Nomura K et al. Association of the metabolic syndrome with depression and anxiety in Japanese men: a 1-year cohort study. Diabet. Metab. Res. Rev.25(8), 762–767 (2009).
   PubMed Web of Science ®Google Scholar
• Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA. No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study. Acta Psychiatr. Scand.120(1), 14–22 (2009).
   PubMed Web of Science ®Google Scholar
• Raikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism51(12), 1573–1577 (2002).
   PubMed Web of Science ®Google Scholar
• Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J. Clin. Psychiatr.69(2), 178–182 (2008).
   PubMed Web of Science ®Google Scholar
• Dunbar JA, Reddy P, Davis-Lameloise N et al. Depression: an important comorbidity with metabolic syndrome in a general population. Diabet. Care31(12), 2368–2373 (2008).
   PubMed Web of Science ®Google Scholar
• Petrlova B, Rosolova H, Hess Z, Podlipny J, Simon J. Depressive disorders and the metabolic syndrome of insulin resistance. Semin. Vasc. Med.4(2), 161–165 (2004).
   PubMedGoogle Scholar
• Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Depressive symptoms are associated with unhealthy lifestyles in hypertensive patients with the metabolic syndrome. J. Hypertens.23(3), 611–617 (2005).
   PubMed Web of Science ®Google Scholar
• Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biolog. Psychiatr.62(11), 1251–1257 (2007).
   PubMed Web of Science ®Google Scholar
• Toker S, Shirom A, Melamed S. Depression and the metabolic syndrome: gender-dependent associations. Depression Anxiety25(8), 661–669 (2008).
   PubMed Web of Science ®Google Scholar
• Nishina M, Nishina K, Ohira T, Makino K, Iso H. Associations of psychological distress with metabolic syndrome among Japanese urban residents. J. Atheroscler. Thromb.18(5), 396–402 (2011).
   PubMed Web of Science ®Google Scholar
• Vogelzangs N, Beekman AT, Kritchevsky SB et al. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the health, aging and body composition study. J. Gerontol.62(5), 563–569 (2007).
   Google Scholar
• Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J. Clin. Endocrinol. Metab.93(11 Suppl. 1), S9–S30 (2008).
   PubMed Web of Science ®Google Scholar
• du Plessis A, Malan L, Malan NT. Coping and metabolic syndrome indicators in urban black South African men: the SABPA study. Cardiovasc. J. Afr.21(5), 268–273 (2010).
   PubMed Web of Science ®Google Scholar
• Malan L, Malan NT, Wissing MP, Seedat YK. Coping with urbanization: a cardiometabolic risk? The THUSA study. Biol. Psychol.79(3), 323–328 (2008).
   PubMed Web of Science ®Google Scholar
• Wang C, Wei D, Wang B et al. Effect of lifestyle on the prevalence of the metabolic syndrome among farmers, migrants with Yi ethnicity and Han population in Sichuan province of China. Asia Pac. J. Clin. Nutr.19(2), 266–273 (2010).
   PubMed Web of Science ®Google Scholar
• Misra A, Singhal N, Sivakumar B, Bhagat N, Jaiswal A, Khurana L. Nutrition transition in india: secular trends in dietary intake and their relationship to diet-related non-communicable diseases. J. Diabet. doi:10.1111/j.1753-0407.2011.00139.x (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Das S, O’Keefe JH. Behavioral cardiology: recognizing and addressing the profound impact of psychosocial stress on cardiovascular health. Curr. Hypertens. Reports10(5), 374–381 (2008).
   PubMedGoogle Scholar
• Epel ES. Psychological and metabolic stress: a recipe for accelerated cellular aging? Hormones (Athens).8(1), 7–22 (2009).
   PubMedGoogle Scholar
• Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities? Obes. Rev.2(2), 73–86 (2001).
   PubMedGoogle Scholar
• Tamashiro KL, Hegeman MA, Sakai RR. Chronic social stress in a changing dietary environment. Physiol. Behav.89(4), 536–542 (2006).
   PubMed Web of Science ®Google Scholar
• Arce M, Michopoulos V, Shepard KN, Ha QC, Wilson ME. Diet choice, cortisol reactivity, and emotional feeding in socially housed rhesus monkeys. Physiol. Behav.101(4), 446–455 (2010).
   PubMed Web of Science ®Google Scholar
• Herva A, Rasanen P, Miettunen J et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: the Northern Finland 1966 birth cohort study. Psychosom. Med.68(2), 213–216 (2006).
   PubMed Web of Science ®Google Scholar
• Lambert E, Dawood T, Straznicky N et al. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J. Hypertens.28(3), 543–550 (2010).
   PubMed Web of Science ®Google Scholar
• van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta. Psychiatr. Scand.122(1), 30–39 (2010).
   PubMed Web of Science ®Google Scholar
• Goldbacher EM, Matthews KA. Are psychological characteristics related to risk of the metabolic syndrome? A review of the literature. Ann. Behav. Med.34(3), 240–252 (2007).
   PubMed Web of Science ®Google Scholar
• Vicennati V, Pasquali R. Abnormalities of the hypothalamic–pituitary–adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration. J. Clin. Endocrinol. Metab.85(11), 4093–4098 (2000).
   PubMed Web of Science ®Google Scholar
• Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD. Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biolog. Psychiatr.66(1), 91–93 (2009).
   PubMed Web of Science ®Google Scholar
• Loh KY, Kew ST. Endocannabinoid system and cardio-metabolic risk. Med. J. Malaysia63(4), 348–350; quiz 351 (2008).
   PubMedGoogle Scholar
• Le Foll B, Gorelick DA, Goldberg SR. The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology205(1), 171–174 (2009).
   PubMed Web of Science ®Google Scholar
• McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev.87(3), 873–904 (2007).
   PubMed Web of Science ®Google Scholar
• Hancock K, Davidson PM, Daly J, Webber D, Chang E. An exploration of the usefulness of motivational interviewing in facilitating secondary prevention gains in cardiac rehabilitation. J. Cardiopulm. Rehabil.25(4), 200–206 (2005).
   PubMedGoogle Scholar
• Bennett JA, Lyons KS, Winters-Stone K, Nail LM, Scherer J. Motivational interviewing to increase physical activity in long-term cancer survivors: a randomized controlled trial. Nurs. Res.56(1), 18–27 (2007).
   PubMed Web of Science ®Google Scholar
• Tripp SB, Perry JT, Romney S, Blood-Siegfried J. Providers as weight coaches: using practice guides and motivational interview to treat obesity in the pediatric office. J. Pediatr. Nurs.26(5), 474–479 (2011).
   PubMedGoogle Scholar
• Adili F, Larijani B, Haghighatpanah M. Diabetic patients: psychological aspects. Ann. NY Acad. Sci.1084, 329–349 (2006).
   PubMed Web of Science ®Google Scholar
• Fisher EB, Thorpe CT, Devellis BM, Devellis RF. Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal. Diabet. Educ.33(6), 1080–1103; discussion 1104–1086 (2007).
   PubMed Web of Science ®Google Scholar
• McGrady A. The effects of biofeedback in diabetes and essential hypertension. Cleve. Clin. J. Med.77(Suppl. 3), S68–S71 (2010).
   Google Scholar
• Christopoulou FD, Kiortsis DN. An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity. J. Clin. Pharm. Ther.36(1), 10–18 (2011).
   PubMed Web of Science ®Google Scholar
• Kruk J. Physical activity in the prevention of the most frequent chronic diseases: an analysis of the recent evidence. Asian Pac. J. Cancer Prev.8(3), 325–338 (2007).
   PubMed Web of Science ®Google Scholar
• Subirats Bayego E, Subirats Vila G, Soteras Martinez I. Exercise prescription: indications, dosage and side effects. Med. Clin. (Barc.) doi:10.1016/j.medcli.2010.12.008 (2011) (Epub ahead of print).
   Google Scholar
• Strohle A. Physical activity, exercise, depression and anxiety disorders. J. Neural. Transm.116(6), 777–784 (2009).
   PubMed Web of Science ®Google Scholar
• Sardinha A, Araujo CG, Soares-Filho GL, Nardi AE. Anxiety, panic disorder and coronary artery disease: issues concerning physical exercise and cognitive behavioral therapy. Exp. Rev. Cardiovasc. Ther.9(2), 165–175 (2011).
   PubMedGoogle Scholar